Good Day BIO Newsletter Archive | July 14, 2022
The FDA has authorized the Novavax COVID-19 vaccine for emergency use, making it the fourth vaccine available in the U.S. We have the details, plus an exclusive interview with a Novavax executive. Plus, we take a look at how biotech is improving cosmetics and beauty products. (697 words, 3 minutes,…